Search Results - "Vallés, Martí"

Genetic Variants Associated with Chronic Kidney Disease in a Spanish Population by Corredor, Zuray, Filho, Miguel Inácio da Silva, Rodríguez-Ribera, Lara, Velázquez, Antonia, Hernández, Alba, Catalano, Calogerina, Hemminki, Kari, Coll, Elisabeth, Silva, Irene, Diaz, Juan Manuel, Ballarin, José, Vallés Prats, Martí, Calabia Martínez, Jordi, Försti, Asta, Marcos, Ricard, Pastor, Susana

“…Chronic kidney disease (CKD) patients have many affected physiological pathways. Variations in the genes regulating these pathways might affect the incidence…”
Get full text

Individualized low-dose drug combinations in pancreatic ductal adenocarcinoma: A phosphoproteomic approach by Vallés Martí, A., Mantini, G., Le Large, T., Pham, T., Piersma, S., Knol, J., Kazemier, G., van Laarhoven, H.W., Bijlsma, M., Giovanetti, E., Jiménez, C.

Get full text

Evaluation of Sentinel-1, SMAP and SMOS surface soil moisture products for distributed eco-hydrological modelling in Mediterranean forest basins by Gomis-Cebolla, José, Garcia-Arias, Alicia, Perpinyà-Vallès, Martí, Francés, Félix

“…•Eco-hydrological distributed models can validate spatial patterns of satellite SSM.•Differences in temporal and spatial dynamics of SSM products were…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study by Martínez-Castelao, Alberto, Cases, Aleix, Carballada, Alberto Torre, Iranzo, Javier Torralba, Bronsoms, Josep, Vallès-Prats, Martí, Monserrat, Daniel Torán, Jimenez, Elisabet Masso

“…The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally exceeding 13 g/dL during…”
Get full text

Challenges and Evolution of Water Level Monitoring towards a Comprehensive, World-Scale Coverage with Remote Sensing by Machefer, Mélissande, Perpinyà-Vallès, Martí, Escorihuela, Maria José, Gustafsson, David, Romero, Laia

“…Surface water availability is a fundamental environmental variable to implement effective climate adaptation and mitigation plans, as expressed by scientific,…”
Get full text

Structural damage in diabetic nephropathy is associated with TNF-α system activity by Fernández-Real, José Manuel, Vendrell, Joan, García, Isabel, Ricart, Wifredo, Vallès, Martí

“…In experimental animal studies, tumour necrosis factor-α (TNF-α) contributed to renal hypertrophy during diabetes, and antibodies against TNF-α have led to…”
Get full text

High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer by Böttger, Franziska, Vallés-Martí, Andrea, Cahn, Loraine, Jimenez, Connie R

“…Mounting evidence indicates that vitamin C has the potential to be a potent anti-cancer agent when administered intravenously and in high doses (high-dose…”
Get full text

Inferring kinase activity from phosphoproteomic data: Tool comparison and recent applications by Piersma, Sander R., Valles‐Marti, Andrea, Rolfs, Frank, Pham, Thang V., Henneman, Alex A., Jiménez, Connie R.

“…Aberrant cellular signaling pathways are a hallmark of cancer and other diseases. One of the most important signaling mechanisms involves protein…”
Get full text

The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies by El Hassouni, Btissame, Granchi, Carlotta, Vallés-Martí, Andrea, Supadmanaba, I Gede Putu, Bononi, Giulia, Tuccinardi, Tiziano, Funel, Niccola, Jimenez, Connie R., Peters, Godefridus J., Giovannetti, Elisa, Minutolo, Filippo

“…Cancer metastasis to distant organs is initiated by tumor cells that disseminate from primary heterogeneous tumors. The subsequent growth and survival of tumor…”
Get full text

Pathologic cervical fracture in a patient with secondary hyperparathyroidism by Faur, Diana, Pérez-Bovet, Jordi, Ferrer, Secundino Martín, Prats, Martí Vallès

Get more information

Kinase activities in pancreatic ductal adenocarcinoma with prognostic and therapeutic avenues by Vallés‐Martí, Andrea, Goeij‐de Haas, Richard R., Henneman, Alex A., Piersma, Sander R., Pham, Thang V., Knol, Jaco C., Verheij, Joanne, Dijk, Frederike, Halfwerk, Hans, Giovannetti, Elisa, Jiménez, Connie R., Bijlsma, Maarten F.

“…Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited number of known driver mutations but considerable cancer cell heterogeneity…”
Get full text

Phosphoproteomics guides effective low-dose drug combinations against pancreatic ductal adenocarcinoma by Vallés-Martí, Andrea, Mantini, Giulia, Manoukian, Paul, Waasdorp, Cynthia, Sarasqueta, Arantza Fariña, de Goeij-de Haas, Richard R., Henneman, Alex A., Piersma, Sander R., Pham, Thang V., Knol, Jaco C., Giovannetti, Elisa, Bijlsma, Maarten F., Jiménez, Connie R.

“…Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with a limited set of known driver mutations but considerable cancer cell heterogeneity…”
Get full text

Doppler ultrasound in the measurement of pulse wave velocity: agreement with the Complior method by Calabia, Jordi, Torguet, Pere, Garcia, Maria, Garcia, Isabel, Martin, Nadia, Guasch, Bernat, Faur, Diana, Vallés, Martí

“…Aortic stiffness is an independent predictor factor for cardiovascular risk. Different methods for determining pulse wave velocity (PWV) are used, among which…”
Get full text

To Combine or Not Combine: Drug Interactions and Tools for Their Analysis. Reflections from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology by El Hassouni, Btissame, Mantini, Giulia, Li Petri, Giovanna, Capula, Mjriam, Boyd, Lenka, Weinstein, Hannah N W, Vallés-Marti, Andrea, Kouwenhoven, Mathilde C M, Giovannetti, Elisa, Westerman, Bart A, Peters, Godefridus J

“…Combination therapies are used in the clinic to achieve cure, better efficacy and to circumvent resistant disease in patients. Initial assessment of the effect…”
Get full text

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma by Drees, Esther E. E., Driessen, Julia, Zwezerijnen, Gerben J. C., Verkuijlen, Sandra A. W. M., Eertink, Jakoba J., Eijndhoven, Monique A. J., Groenewegen, Nils J., Vallés‐Martí, Andrea, Jong, Daphne, Boellaard, Ronald, Vet, Henrica C. W., Pegtel, Dirk M., Zijlstra, Josée M.

“…Blood‐based biomarkers are gaining interest for response evaluation in classical Hodgkin lymphoma (cHL). However, it is unknown how blood‐based biomarkers…”
Get full text

The Relationship Between Renal Resistive Index, Arterial Stiffness, and Atherosclerotic Burden: The Link Between Macrocirculation and Microcirculation by Calabia, Jordi, Torguet, Pere, Garcia, Isabel, Martin, Nadia, Mate, Gerard, Marin, Adriana, Molina, Carolina, Valles, Marti

“…The renal resistive index (RRI) measured by Doppler sonography is a marker of microvascular status that can be generalized to the whole of the arterial tree…”
Get full text

Extracellular vesicle miRNA predict FDG‐PET status in patients with classical Hodgkin Lymphoma by Drees, Esther E. E., Roemer, Margaretha G. M., Groenewegen, Nils J., Perez‐Boza, Jennifer, Eijndhoven, Monique A. J., Prins, Leah I., Verkuijlen, Sandra A. W. M., Tran, Xuan‐Mai, Driessen, Julia, Zwezerijnen, G. J. C., Stathi, Phylicia, Mol, Kevin, Karregat, Joey J. J. P., Kalantidou, Aikaterini, Vallés‐Martí, Andrea, Molenaar, T. J., Aparicio‐Puerta, Ernesto, Dijk, Erik, Ylstra, Bauke, Groothuis‐Oudshoorn, Catharina G. M., Hackenberg, Michael, Jong, Daphne, Zijlstra, Josée M., Pegtel, D. Michiel

“…Minimally‐invasive tools to assess tumour presence and burden may improve clinical management. FDG‐PET (metabolic) imaging is the current gold standard for…”
Get full text

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1 by Martínez-Castelao, Alberto, Cases, Aleix, Carballada, Alberto Torre, Iranzo, Javier Torralba, Bronsoms, Josep, Vallès-Prats, Martí, Monserrat, Daniel Torán, Jimenez, Elisabet Masso

“…The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12g/dL, without intentionally exceeding 13g/dL during…”
Get full text

Does the obesity survival paradox of dialysis patients differ with age? by Calabia, Jordi, Arcos, Emma, Carrero, Juan Jesús, Comas, Jordi, Vallés, Martí

“…The obesity paradox of hemodialysis patients (the association between obesity and survival) could be modified by age. We hypothesize that whereas obesity…”
Get more information

Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study1 by Martínez-Castelao, Alberto, Cases, Aleix, Torre Carballada, Alberto, Torralba Iranzo, Javier, Bronsoms, Josep, Vallès-Prats, Martí, Torán Monserrat, Daniel, Masso Jimenez, Elisabet

“…Background and objective: The Anemia Working Group of ERBP in 2010 recommended a target hemoglobin (Hb) level in the range of 11-12 g/dL, without intentionally…”
Get full text